Azusa Tanimoto

5PUBLICATIONS
55CO-AUTHORS
Predictive and prognostic markersMolecular targetsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 16, 2024
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities.

C Allison Stewart, Lixia Diao, Yuanxin Xi

|Jun 08, 2023
Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer.

Kavya Ramkumar, Azusa Tanimoto, Carminia M Della Corte

|Mar 01, 2021
Multi-institutional survey of cancer disparities in disabled patients in the region of northwestern Japan.

Shigeki Sato, Azusa Tanimoto, Naohiro Yanagimura

|Sep 15, 2020
Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer.

Rong Wang, Tadaaki Yamada, Kenji Kita

|Dec 14, 2018
Pulmonary carcinosarcoma showing an obvious response to pazopanib: a case report.

Azusa Tanimoto, Shinji Takeuchi, Hiroshi Kotani

Pageof 1